Category Archives: Strategy

Customer Engagement Isn’t Just About Physicians: It’s About Sales Reps Too

By Karl Tiedemann. Managing the pharma sales force has always been challenging. Reps are spread out geographically, often far from corporate offices, preventing them from taking part in the on-site activities and face-to-face interactions that typically foster a connection to the company. In order to help the sales force achieve their primary goal — educating […]
Also posted in Guest Blog, Sales | Tagged | 1 Comment

The “Value” of Rx’s Under Obamacare

In the wake of last week’s declaration by new HHS Secretary, Sylvia Burwell, that “Obamacare is working”, it’s probably time for American Rx product managers and marketers to step back and consider where we have travelled since January 1st of this year. Here are a few key remembrances:
Posted in Strategy | 2 Comments

Europe and Canada Welcome Trade Agreement Text

The European Federation of Pharmaceutical Industries and Associations (EFPIA) and Canada’s Research-Based Pharmaceutical Companies (Rx&D) have welcome finalization of the text for the Comprehensive Economic and Trade Agreement (CETA). CETA represents the first free trade agreement between any G8 country. EFPIA and Rx&D believe it will, once in place, be beneficial to patients on both […]
Also posted in Europe, Global | Tagged , , | Leave a comment

Email Marketing's Growing Maturity

Email marketing is still very much with us, despite much talk of its demise. But, writes Peter Houston, it has moved on from its “spammy” adolescence. Scary tales of The-Next-Big-Social-Thing killing off the first digital marketing blockbuster have been building for years. McKinsey’s November 2013  iConsumer survey reported a 20 percent decline in email usage […]
Also posted in Marketing, Op-Ed, Patient Communication, social media | Tagged , , | Leave a comment

Pharma M&A: Diverse and Accelerating

By Peter Young. I have been involved with the pharmaceutical and biotech industries, as a strategy consultant with Bain & Company, a venture capitalist with J.H. Whitney, and as an investment banker with Salomon Brothers, Lehman Brothers and Young & Partners. Over that period of time, I have never seen as many different strategies being […]
Posted in Strategy | Leave a comment
  • Categories

  • Meta